Clinical and patient characteristics associated with severe outcome in diphenhydramine toxicity.


Journal

Clinical toxicology (Philadelphia, Pa.)
ISSN: 1556-9519
Titre abrégé: Clin Toxicol (Phila)
Pays: England
ID NLM: 101241654

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 6 3 2021
medline: 9 11 2021
entrez: 5 3 2021
Statut: ppublish

Résumé

Diphenhydramine is frequently misused and ingested recreationally for its antihistaminergic and antimuscarinic effects and is often involved in both serious and fatal poisonings, either in isolation or in combination with other xenobiotics. This analysis sought to determine which patient and encounter characteristics were associated with severe outcome after diphenhydramine overdose. This is an analysis of the multi-center ToxIC registry (2010-2016). Descriptive analysis of all cases with diphenhydramine listed as the "primary agent" contributing to toxicity were included. Analysis sought to determine which patient and encounter characteristics were associated with severe outcome, defined as occurrence of seizure, ventricular dysrhythmia, or intubation. To determine which patient and encounter characteristics were individually associated with severe outcome, we performed chi-square tests. Fisher's exact tests were used in the case of sparse data. We also performed multivariable logistic regression to further determine independent risk factors for severe outcome in diphenhydramine overdose. Eight hundred and sixty-three cases remained after exclusion with 15.6% ( Acidemia, QRS prolongation, and elevated anion gap are associated with severe outcomes in diphenhydramine toxicity. Further research is warranted to determine their predictive characteristics.

Sections du résumé

BACKGROUND BACKGROUND
Diphenhydramine is frequently misused and ingested recreationally for its antihistaminergic and antimuscarinic effects and is often involved in both serious and fatal poisonings, either in isolation or in combination with other xenobiotics.
OBJECTIVE OBJECTIVE
This analysis sought to determine which patient and encounter characteristics were associated with severe outcome after diphenhydramine overdose.
METHODS METHODS
This is an analysis of the multi-center ToxIC registry (2010-2016). Descriptive analysis of all cases with diphenhydramine listed as the "primary agent" contributing to toxicity were included. Analysis sought to determine which patient and encounter characteristics were associated with severe outcome, defined as occurrence of seizure, ventricular dysrhythmia, or intubation. To determine which patient and encounter characteristics were individually associated with severe outcome, we performed chi-square tests. Fisher's exact tests were used in the case of sparse data. We also performed multivariable logistic regression to further determine independent risk factors for severe outcome in diphenhydramine overdose.
RESULTS RESULTS
Eight hundred and sixty-three cases remained after exclusion with 15.6% (
DISCUSSION CONCLUSIONS
Acidemia, QRS prolongation, and elevated anion gap are associated with severe outcomes in diphenhydramine toxicity. Further research is warranted to determine their predictive characteristics.

Identifiants

pubmed: 33666139
doi: 10.1080/15563650.2021.1891244
doi:

Substances chimiques

Histamine H1 Antagonists 0
Illicit Drugs 0
Muscarinic Antagonists 0
Diphenhydramine 8GTS82S83M

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

918-925

Auteurs

Adrienne R Hughes (AR)

Department of Emergency Medicine, Oregon Health and Science University, Portland, OR, USA.
Oregon Poison Center, Portland, OR, USA.

Amber Lin (A)

Department of Emergency Medicine, Center for Policy and Research in Emergency Medicine, Oregon Health and Science University, Portland, OR, USA.

Robert G Hendrickson (RG)

Department of Emergency Medicine, Oregon Health and Science University, Portland, OR, USA.
Oregon Poison Center, Portland, OR, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH